Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 36,176 $ 40,406
Accounts receivable, net of allowances of $19 and $28, respectively 3,346 4,662
Inventories 2,772 2,242
Prepaid expenses and other current assets 829 485
Total current assets 43,123 47,795
Property and equipment, net 886 991
Right-of-use assets 92 216
Other assets 141 164
Total assets 44,242 49,166
Current liabilities:    
Accounts payable 2,939 3,107
Accrued liabilities 1,819 2,299
Deferred revenues, current 1,115 1,220
Lease liabilities, current 97 229
Total current liabilities 5,970 6,855
Deferred revenues 1,082 1,475
Notes payable, net 1,994 1,993
Warrant liabilities 1,650 1,550
Other non-current liabilities 60 74
Total liabilities 10,756 11,947
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Convertible preferred stock, $0.001 par value; 10,000 shares authorized; none issued and outstanding at March 31, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value; 141,429 shares authorized; 12,844 and 12,693 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 13 13
Additional paid-in capital 246,765 246,090
Accumulated other comprehensive gain (loss) 195 (17)
Accumulated deficit (213,487) (208,867)
Total stockholders’ equity 33,486 37,219
Total liabilities and stockholders’ equity $ 44,242 $ 49,166